Johnson & Johnson Announces $55 Billion U.S. Investment Over Four Years

• Johnson & Johnson will invest over $55 billion in U.S. manufacturing, research, and technology over the next four years, a 25% increase compared to the previous period.

• The company has broken ground on a 500,000-square-foot biologics manufacturing facility in Wilson, North Carolina, set to create over 500 jobs and contribute $3 billion to the state’s economy in its first decade.

Johnson & Johnson has announced a $55 billion investment in U.S. manufacturing, research, and technology over the next four years, marking a 25% increase over the previous period. The initiative builds upon the company’s existing U.S. investment levels, which were elevated following the passage of the 2017 Tax Cuts & Jobs Act.

The investment includes the construction of three advanced manufacturing facilities, expansion of existing sites, and enhancements in R&D infrastructure across its Innovative Medicine and MedTech businesses. These developments will support drug discovery, workforce training, and operational advancements in areas such as oncology, neuroscience, immunology, cardiovascular disease, and robotic surgery.

A key part of this initiative is the newly launched high-tech biologics manufacturing facility in Wilson, North Carolina. The 500,000-square-foot site will expand Johnson & Johnson’s capacity to produce next-generation medicines for cancer, immune-mediated, and neurological diseases. The facility is expected to support approximately 5,000 jobs during construction and create over 500 permanent positions, generating a $3 billion economic impact for North Carolina within its first 10 years of operation.

“Our increased U.S. investment begins with the ground-breaking of a high-tech facility in North Carolina that will not only add U.S.-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world,” said Joaquin Duato, Chairman and CEO of Johnson & Johnson.

The Trump Effect

The White House has said this is “the latest massive victory in President Donald J. Trump’s unrelenting pursuit of American manufacturing dominance” adding that “President Trump will stop at nothing to restore American manufacturing and bring jobs back where they belong — right here in the U.S.”

Other recent announcements include Merck investing $8 billion in the U.S. over the next several years after opening its new $1 billion North Carolina manufacturing facility, and Eli Lilly announcing a $27 billion investment in U.S.-based manufacturing.